Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-15
DOI
10.1038/s41467-020-16199-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance
- (2019) Jonathan Cooper et al. CANCER CELL
- Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and Structure–Activity Relationships
- (2019) Leo Leung et al. JOURNAL OF MEDICINAL CHEMISTRY
- Integrins as biomechanical sensors of the microenvironment
- (2019) Jenny Z. Kechagia et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
- (2018) Norman Sachs et al. CELL
- PRDM1 silences stem cell-related genes and inhibits proliferation of human colon tumor organoids
- (2018) Changlong Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Site-specific expression of amine oxidases in breast cancer metastases
- (2018) Yoon Jin Cha et al. TUMOR BIOLOGY
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hypoxia Selectively Enhances Integrin α 5 β 1 Receptor Expression in Breast Cancer to Promote Metastasis
- (2017) Julia A. Ju et al. MOLECULAR CANCER RESEARCH
- Small Molecule Lysyl Oxidase-like 2 (LOXL2) Inhibitors: The Identification of an Inhibitor Selective for LOXL2 over LOX
- (2017) John H. Hutchinson et al. ACS Medicinal Chemistry Letters
- Blocking Surgically Induced Lysyl Oxidase Activity Reduces the Risk of Lung Metastases
- (2017) Chen Rachman-Tzemah et al. Cell Reports
- Stimulation of triple negative breast cancer cell migration and metastases formation is prevented by chloroquine in a pre-irradiated mouse model
- (2016) Gina Bouchard et al. BMC CANCER
- Lysyl Oxidase, a Targetable Secreted Molecule Involved in Cancer Metastasis
- (2016) Thomas R. Cox et al. CANCER RESEARCH
- Lysyl Oxidase (LOX) Transcriptionally Regulates SNAI2 Expression and TIMP4 Secretion in Human Cancers
- (2016) M. Boufraqech et al. CLINICAL CANCER RESEARCH
- Chemotherapy for Triple-Negative Breast Cancer: Is More Better?
- (2016) Erica L. Mayer et al. JOURNAL OF CLINICAL ONCOLOGY
- Hyaluronidase Embedded in Nanocarrier PEG Shell for Enhanced Tumor Penetration and Highly Efficient Antitumor Efficacy
- (2016) Hao Zhou et al. NANO LETTERS
- Lysyl oxidase family activity promotes resistance of pancreatic ductal adenocarcinoma to chemotherapy by limiting the intratumoral anticancer drug distribution
- (2016) Benjamin Le Calvé et al. Oncotarget
- Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) E. Senkus et al. ANNALS OF ONCOLOGY
- Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy
- (2015) Bryan W Miller et al. EMBO Molecular Medicine
- Hypoxia increases the abundance but not the assembly of extracellular fibronectin during epithelial cell transdifferentiation
- (2015) M. K. Rana et al. JOURNAL OF CELL SCIENCE
- Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance
- (2015) Laetitia Seguin et al. TRENDS IN CELL BIOLOGY
- Mechanical forces regulate the interactions of fibronectin and collagen I in extracellular matrix
- (2015) Kristopher E. Kubow et al. Nature Communications
- Inhibition of Lysyl Oxidases Improves Drug Diffusion and Increases Efficacy of Cytotoxic Treatment in 3D Tumor Models
- (2015) Friedrich Schütze et al. Scientific Reports
- Remodelling the extracellular matrix in development and disease
- (2014) Caroline Bonnans et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Robust Prognostic Gene Expression Signatures in Bladder Cancer and Lung Adenocarcinoma Depend on Cell Cycle Related Genes
- (2014) Garrett M. Dancik et al. PLoS One
- Hypoxia inducible factor pathway inhibitors as anticancer therapeutics
- (2013) Sarah K Burroughs et al. Future Medicinal Chemistry
- Hypoxia-inducible Factor 1 (HIF-1) Promotes Extracellular Matrix Remodeling under Hypoxic Conditions by InducingP4HA1, P4HA2,andPLOD2Expression in Fibroblasts
- (2013) Daniele M. Gilkes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Integrin α5β1, the Fibronectin Receptor, as a Pertinent Therapeutic Target in Solid Tumors
- (2013) Florence Schaffner et al. Cancers
- Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer
- (2012) Stefan Uhlmann et al. Molecular Systems Biology
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- Pathological Complete Response and Accelerated Drug Approval in Early Breast Cancer
- (2012) Tatiana M. Prowell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lysyl oxidase enzymatic function increases stiffness to drive colorectal cancer progression through FAK
- (2012) A-M Baker et al. ONCOGENE
- The HIF-1-Inducible Lysyl Oxidase Activates HIF-1 via the Akt Pathway in a Positive Regulation Loop and Synergizes with HIF-1 in Promoting Tumor Cell Growth
- (2011) F. Pez et al. CANCER RESEARCH
- The Role of Lysyl Oxidase in SRC-Dependent Proliferation and Metastasis of Colorectal Cancer
- (2011) Ann-Marie Baker et al. JNCI-Journal of the National Cancer Institute
- Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
- (2011) C. C.-L. Wong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA control of signal transduction
- (2010) Masafumi Inui et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- The dual kinase complex FAK-Src as a promising therapeutic target in cancer
- (2010) Victoria Bolós OncoTargets and Therapy
- Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche
- (2009) Janine T. Erler et al. CANCER CELL
- Lysyl oxidase as a potential therapeutic target
- (2009) C. Rodríguez et al. DRUG NEWS & PERSPECTIVES
- Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes
- (2008) A M Calcagno et al. BRITISH JOURNAL OF CANCER
- How basal are triple-negative breast cancers?
- (2008) François Bertucci et al. INTERNATIONAL JOURNAL OF CANCER
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started